Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Persistently elevated exhaled nitric oxide fraction is associated with increased risk of exacerbation in COPD
Bernardino Alcázar Navarrete, Oliverio Ruiz Rodríguez, Pablo Conde Baena, et al.
European Respiratory Journal (2018) Vol. 51, Iss. 1, pp. 1701457-1701457
Open Access | Times Cited: 52

Showing 1-25 of 52 citing articles:

Type-2 inflammation and lung function decline in chronic airway disease in the general population
Yunus Çolak, Shoaib Afzal, Jacob Louis Marott, et al.
Thorax (2024), pp. thorax-220972
Open Access | Times Cited: 16
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2019 Report: Future Challenges
José Luís López-Campos, Juan José Soler‐Cataluña, Marc Miravitlles
Archivos de Bronconeumología (2019) Vol. 56, Iss. 2, pp. 65-67
Closed Access | Times Cited: 85
Targeting Type 2 Inflammation and Epithelial Alarmins in Chronic Obstructive Pulmonary Disease: A Biologics Outlook
Klaus F. Rabe, Stephen I. Rennard, Fernando J. Martínez, et al.
American Journal of Respiratory and Critical Care Medicine (2023) Vol. 208, Iss. 4, pp. 395-405
Closed Access | Times Cited: 33
Exhaled Nitric Oxide as Biomarker of Type 2 Diseases
Mauro Maniscalco, Salvatore Fuschillo, Ilaria Mormile, et al.
Cells (2023) Vol. 12, Iss. 21, pp. 2518-2518
Open Access | Times Cited: 24
Fractional nitric oxide measurement in exhaled air (FeNO): perspectives in the management of respiratory diseases
Beatrice Ragnoli, Alessandro Radaeli, Patrizia Pochetti, et al.
Therapeutic Advances in Chronic Disease (2023) Vol. 14
Open Access | Times Cited: 18
Combined value of exhaled nitric oxide and blood eosinophils in chronic airway disease: the Copenhagen General Population Study
Yunus Çolak, Shoaib Afzal, Børge G. Nordestgaard, et al.
European Respiratory Journal (2018) Vol. 52, Iss. 2, pp. 1800616-1800616
Open Access | Times Cited: 53
The Relevance of Targeting Treatment to Small Airways in Asthma and COPD
Pierachille Santus, Dejan Radovanovic, Matteo Pecchiari, et al.
Respiratory Care (2020) Vol. 65, Iss. 9, pp. 1392-1412
Open Access | Times Cited: 40
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2019 Report: Future Challenges
Josèc Luis López-Campos, Juan José Soler‐Cataluña, Marc Miravitlles
Archivos de Bronconeumología (2020) Vol. 56, Iss. 2, pp. 65-67
Closed Access | Times Cited: 39
Immune Dysregulation in Chronic Obstructive Pulmonary Disease
Xichen Pang, Xiaoju Liu
Immunological Investigations (2024) Vol. 53, Iss. 4, pp. 652-694
Closed Access | Times Cited: 4
What Every Clinician Should Know About Inflammation in COPD
Michael E. Wechsler, J. Michael Wells
ERJ Open Research (2024) Vol. 10, Iss. 5, pp. 00177-2024
Open Access | Times Cited: 4
Small airways disease in chronic obstructive pulmonary disease
Nikolaos Lazarinis, Evangelia Fouka, Anders Lindén, et al.
Expert Review of Respiratory Medicine (2024) Vol. 18, Iss. 7, pp. 539-552
Open Access | Times Cited: 4
Markers of T2-airway inflammation in patients with chronic obstructive pulmonary disease
Galina Sergeeva, Alexander Emelyanov, E. V. Leshenkova, et al.
Terapevticheskii arkhiv (2025) Vol. 97, Iss. 3, pp. 250-256
Open Access
Short term exacerbation risk and exhaled nitric oxide in COPD
A Romero Linares, Luis A Muro, Abdul Majeed Alwan Hammadi, et al.
Respiratory Medicine (2025), pp. 108134-108134
Closed Access
Role of Type2 Inflammatory Biomarkers in Chronic Obstructive Pulmonary Disease
Keiji Oishi, Kazuto Matsunaga, Toshihiro Shirai, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 8, pp. 2670-2670
Open Access | Times Cited: 32
Exhaled nitric oxide levels in COPD patients who use electronic cigarettes
Andrew Higham, Augusta Beech, Dave Singh
Nitric Oxide (2024) Vol. 145, pp. 57-59
Open Access | Times Cited: 3
Comorbid Conditions in Chronic Obstructive Pulmonary Disease: Potential Therapeutic Targets for Unmet Needs
Kazuto Matsunaga, Misa Harada, Junki Suizu, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 10, pp. 3078-3078
Open Access | Times Cited: 25
Central and peripheral airway nitric oxide in patients with stable and exacerbated chronic obstructive pulmonary disease
Zsόfia Lázár, Ágnes Kelemen, Gabriella Gálffy, et al.
Journal of Breath Research (2018) Vol. 12, Iss. 3, pp. 036017-036017
Closed Access | Times Cited: 27
Fractional Exhaled Nitric Oxide is Associated with the Severity of Stable COPD
Xiaoqian Liu, Hong Zhang, Ying Wang, et al.
COPD Journal of Chronic Obstructive Pulmonary Disease (2020) Vol. 17, Iss. 2, pp. 121-127
Closed Access | Times Cited: 19
Clinical Utility of Central and Peripheral Airway Nitric Oxide in Aging Patients with Stable and Acute Exacerbated Chronic Obstructive Pulmonary Disease
Xiaodong Fan, Nian Zhao, Zhen Yu, et al.
International Journal of General Medicine (2021) Vol. Volume 14, pp. 571-580
Open Access | Times Cited: 16
Clinical utilization of airway inflammatory biomarkers in the prediction and monitoring of clinical outcomes in patients with chronic obstructive pulmonary disease
Dina Yehia, Clarus Leung, Don D. Sin
Expert Review of Molecular Diagnostics (2024) Vol. 24, Iss. 5, pp. 409-421
Closed Access | Times Cited: 2
Association between Acute Tobacco Exposure and Fractional Exhaled Nitric Oxide in Patients with Chronic Obstructive Pulmonary Disease: National Health and Nutrition Examination Survey (NHANES) 2007–2012
X Hou, C. Hou
Respiratory Medicine (2024) Vol. 234, pp. 107831-107831
Open Access | Times Cited: 2
Type 2 inflammation in COPD: is it just asthma?
Augusta Beech, Andrew Higham, Sophie Booth, et al.
Breathe (2024) Vol. 20, Iss. 3, pp. 230229-230229
Open Access | Times Cited: 2
Variability of fractional exhaled nitric oxide is associated with the risk and aetiology of COPD exacerbations
Desirée Schumann, Eleni Papakonstantinou, Κonstantinos Κostikas, et al.
Respirology (2022) Vol. 28, Iss. 5, pp. 445-454
Closed Access | Times Cited: 10
The role of FeNO in stable COPD patients with eosinophilic airway inflammation
Stefanie Vincken, Sylvia Verbanck, Daniël Schuermans, et al.
Respiratory Medicine (2021) Vol. 181, pp. 106377-106377
Open Access | Times Cited: 14
Exhaled nitric oxide, eosinophils and current smoking in COPD patients
Andrew Higham, Augusta Beech, James P. Dean, et al.
ERJ Open Research (2023) Vol. 9, Iss. 6, pp. 00686-2023
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top